Heart Rate Variability in Pneumothorax

NCT ID: NCT03537417

Last Updated: 2018-05-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-06-01

Study Completion Date

2019-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Changes in heart rate variability in anesthetized, ventilated patients undergoing tension pneumothorax for thoracoscopic cervical sympathectomy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumothorax

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tension pneumothorax group

Patients undergoing intentional pneumothorax for thoracoscopic ablation of cervical sympathetic chain as a treatment for hyperhidrosis

for thoracoscopic ablation of cervical sympathetic chain

Intervention Type PROCEDURE

bilateral thoracoscopic ablation of cervical sympathetic chain as a treatment for hyperhidrosis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

for thoracoscopic ablation of cervical sympathetic chain

bilateral thoracoscopic ablation of cervical sympathetic chain as a treatment for hyperhidrosis

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 15 - 50 years
* body mass index 25 - 45

Exclusion Criteria

* heart rate other than sinus
* cardiac pacemaker status
* heart transplant
Minimum Eligible Age

15 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rambam Health Care Campus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Amit Lehavi MD FANZCA

Director of Pediatric Anesthesia

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Amit Lehavi, MD

Role: CONTACT

972-50-20161419

Amit Lehavi, MD

Role: CONTACT

972-50-2061419

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RMB 144-18

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Automated Real-time Feedback on CPR Study
NCT00539539 COMPLETED PHASE2
The PneumoRator Study
NCT07293299 RECRUITING